According to Perspective Therapeutics's latest financial reports and stock price the company's current Operating Margin is -67.36%. At the end of 2022 the company had an Operating Margin of -67.36%.
Year | Operating Margin | Change |
---|---|---|
2022 | -67.36% | 99.95% |
2021 | -33.69% | -5.36% |
2020 | -35.60% | -49.38% |
2019 | -70.33% | -37.83% |
2018 | -113.12% | -12.6% |
2017 | -129.43% | 31.02% |
2016 | -98.78% | 23.61% |
2015 | -79.92% | -43.42% |
2014 | -141.24% | 65.73% |
2013 | -85.22% | 23.87% |
2012 | -68.80% | 26.82% |
2011 | -54.25% | -28.91% |
2010 | -76.31% | -36.1% |
2009 | -119.43% | -2.87% |
2008 | -122.97% | -27.26% |
2007 | -169.04% | -58.98% |
2006 | -412.08% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.